Valuation: Sunmax Biotechnology Co., Ltd.

Capitalization 21.57B 683M 588M 548M 510M 949M 61.72B 1.02B 6.3B 2.48B 29.51B 2.56B 2.51B 108B P/E ratio 2023
17.8x
P/E ratio 2024 22.5x
Enterprise value 20.85B 660M 569M 530M 493M 917M 59.66B 984M 6.09B 2.4B 28.52B 2.48B 2.43B 105B EV / Sales 2023
6.11x
EV / Sales 2024 7.99x
Free-Float
60.33%
Yield 2023
5.39%
Yield 2024 4.14%
More valuation ratios * Estimated data
Dynamic Chart
Nov. 14 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
25-08-13 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
25-05-13 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-03-17 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
25-03-13 Sunmax Biotechnology Co., Ltd. announces Annual dividend, payable on August 28, 2025 CI
24-11-14 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
24-08-14 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
24-05-14 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
24-03-15 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
23-11-12 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
23-08-10 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
23-05-14 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
23-03-30 Sunmax Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
More news
1 day+1.28%
1 week-0.13%
Current month+0.25%
1 month+1.53%
3 months+1.15%
6 months-0.38%
Current year+0.25%
More quotes
1 week 384.5
Extreme 384.5
397
1 month 384
Extreme 384
413
Current year 384.5
Extreme 384.5
402.5
1 year 271
Extreme 271
501
3 years 119
Extreme 119
501
5 years 64.6
Extreme 64.6
501
10 years 26.75
Extreme 26.75
501
More quotes
Manager TitleAgeSince
Chief Executive Officer - 2014-05-13
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 2002-09-10
Director TitleAgeSince
Chairman - -
Director/Board Member - 2008-06-29
Director/Board Member - 2006-03-28
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.28%-0.13%+43.06%+199.62% 676M
+1.11%+2.66%+4.99%+15.10% 49.05B
-0.03%-1.23%+21.88%+8.62% 41.1B
-2.44%+1.32%+68.31%+24.99% 38.37B
-0.47%-0.24%+18.66%+36.02% 31.59B
+1.69%+20.02%+209.49%+309.67% 23.43B
+0.26%+0.81%+86.77%+170.41% 17.36B
-14.53%-43.15%+23,402.74%+3,721.51% 17.39B
+0.64%+5.01%+57.25%+12.41% 14.83B
-1.20%-10.03%-8.83%-18.68% 14.11B
Average -1.37%-1.65%+2,390.43%+447.97% 24.79B
Weighted average by Cap. -1.09%-0.53%+1,688.17%+315.36%
See all sector performances

Financials

2023 2024
Net sales 1.69B 53.5M 46.08M 42.95M 39.95M 74.33M 4.83B 79.74M 493M 194M 2.31B 201M 197M 8.48B 1.82B 57.59M 49.61M 46.23M 43.01M 80.01M 5.2B 85.83M 531M 209M 2.49B 216M 212M 9.13B
Net income 626M 19.82M 17.07M 15.91M 14.8M 27.54M 1.79B 29.54M 183M 71.93M 856M 74.32M 72.8M 3.14B 679M 21.52M 18.54M 17.28M 16.07M 29.9M 1.94B 32.07M 198M 78.11M 930M 80.7M 79.05M 3.41B
Net Debt -793M -25.11M -21.63M -20.16M -18.75M -34.89M -2.27B -37.43M -232M -91.14M -1.08B -94.16M -92.24M -3.98B -720M -22.81M -19.65M -18.31M -17.04M -31.7M -2.06B -34M -210M -82.8M -985M -85.55M -83.8M -3.62B
More financial data * Estimated data
Logo Sunmax Biotechnology Co., Ltd.
Sunmax Biotechnology Co Ltd is a Taiwan-based company principally engaged in the research, development, manufacture and sale of collagen implants and related products. The Company's principal business includes the manufacture and sale of collagen implants, medical cosmetic care products and collagen-applied medical materials. The Company's products include collagen, absorbable collagen membranes, dental bone fillers and collagen bone fillers. The Company's products are primarily used in medical and aesthetic care applications. The Company sells its products primarily in Taiwan, China and other regions.
Employees
-
More about the company
Date Price Change Volume
26-01-15 397.00 NT$ +1.28% 1,105
26-01-14 392.00 NT$ -0.88% 2,083
26-01-13 395.50 NT$ +0.51% 5,055
26-01-12 393.50 NT$ +0.90% 74,179
26-01-09 390.00 NT$ -1.27% 53,073

End-of-day quote Taipei Exchange, January 14, 2026

More quotes